Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.

Molecular oncology - 1 Mar 2017

van Dessel Lisanne F, Beije Nick, Helmijr Jean C A, Vitale Silvia R, Kraan Jaco, Look Maxime P, de Wit Ronald, Sleijfer Stefan, Jansen Maurice P H M, Martens John W M, Lolkema Martijn P

Abstract excerpt

Circulating tumor DNA (ctDNA) has emerged as a potential new biomarker with diagnostic, predictive, and prognostic applications for various solid tumor types. Before beginning large prospective clinical trials to prove the added value of utilizing ctDNA in clinical practice, it is essential to investigate the effects of various preanalytical conditions on the quality of cell-free DNA (cfDNA) in general and of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Specimen Collection
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Edetic Acid

Share to Genotyping Techniques

Share to Indicators and Reagents

Share to Neoplasms

Share to Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 28164427
DOI: 10.1002/1878-0261.12037
PMCID: PMC5527445

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.PMID 28164427Read ↗

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoringSemantic proximity Read ↗

Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer PatientsSemantic proximity Read ↗

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewSemantic proximity Read ↗

Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients.Semantic proximity Read ↗

Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in OncologySemantic proximity Read ↗

The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.Semantic proximity Read ↗

Considerations and quality controls when analyzing cell-free tumor DNASemantic proximity Read ↗

Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratorySemantic proximity Read ↗

Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sampleSemantic proximity Read ↗

Circulating Tumor DNA in Cancer Management.Semantic proximity Read ↗

The translational potential of circulating tumour DNA in oncology.Semantic proximity Read ↗

Collection of cell-free DNA for genomic analysis of solid tumors in a clinical laboratory settingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.